Medicus Pharma Ltd. Common Stock(MDCX)

Biotechnology · West Conshohocken, PA

$0.16-0.01 (-4.61%)

Delayed quote: Oct 6, 2026, 12:34 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T16:38:02.329Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:38:02.329Z.

Quote observation: 2026-10-06T16:34:43.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.1593
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.62

FMP input reference: 47811cd6fce140e68777d2609bf88a35ade871fb75fdb0cf4ca3c33c868081b2

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

MDCX PE Ratio Metrics

PE RATIO

N/A

MDCX Competitors' PE Ratio

MDCX

Medicus Pharma Ltd. Common Stock

Current

Market Cap

$10.06M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFWD

Lifeward Ltd.

vs MDCX

Market Cap

$9.92M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs MDCX

Market Cap

$10.38M

PE Ratio

N/A

TTM Avg

2.09

3Y Avg

2.09

5Y Avg

2.09

AIMD

Ainos, Inc.

vs MDCX

Market Cap

$9.72M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MSLE

Satellos Bioscience Inc.

vs MDCX

Market Cap

$10.36M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MTVA

MetaVia Inc.

vs MDCX

Market Cap

$9.68M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GDTC

CytoMed Therapeutics Limited

vs MDCX

Market Cap

$10.52M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMTC

NeuroOne Medical Technologies Corporation

vs MDCX

Market Cap

$9.57M

PE Ratio

N/A

TTM Avg

3.33

3Y Avg

3.33

5Y Avg

3.33

SNTI

Senti Biosciences, Inc.

vs MDCX

Market Cap

$10.31M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLRZ

Polyrizon Ltd.

vs MDCX

Market Cap

$10.70M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Medicus Pharma Ltd. Common Stock (MDCX)	$10.06M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$9.92M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.38M	N/A	2.09	2.09	2.09
Ainos, Inc. (AIMD)vs ›	$9.72M	N/A	N/A	N/A	N/A
Satellos Bioscience Inc. (MSLE)vs ›	$10.36M	N/A	N/A	N/A	N/A
MetaVia Inc. (MTVA)vs ›	$9.68M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$10.52M	N/A	N/A	N/A	N/A
NeuroOne Medical Technologies Corporation (NMTC)vs ›	$9.57M	N/A	3.33	3.33	3.33
Senti Biosciences, Inc. (SNTI)vs ›	$10.31M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.70M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.16

Forward EPS (Est.)

$-0.67

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

MDCX PE Ratio Metrics

MDCX Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics